Minims Fenylefrinehydrochloride (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride, the active ingredient in Minims Fenylefrinehydrochloride, is a Alpha‑adrenergic agonist presented as an ophthalmic solution for ocular use. It dilates the pupil and reduces ocular redness, primarily for patients undergoing eye examinations or requiring ocular decongestion.

GNH USA supplies Minims Fenylefrinehydrochloride as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Phenylephrine Hydrochloride acts as an alpha‑adrenergic agonist to produce mydriasis and ocular decongestion.

Eye examination (mydriasis): provides pupil dilation to facilitate detailed retinal and anterior segment assessment. Ocular redness (decongestant): reduces conjunctival hyperemia for improved comfort and visual clarity. Pre‑surgical ocular preparation: minimizes redness and enhances surgical field visibility during ophthalmic procedures.

Phenylephrine Hydrochloride may cause ocular and systemic reactions.

Common Side Effects: - Transient stinging or burning sensation upon instillation. - Temporary blurred vision due to pupil dilation. - Mild conjunctival irritation or itching. - Mild headache in sensitive individuals. - Slight increase in intra‑ocular pressure that resolves quickly.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma in predisposed patients. - Severe allergic reaction (e.g., rash, swelling, difficulty breathing). - Persistent elevated intra‑ocular pressure requiring medical attention. - Corneal edema or ulceration with improper use. - Systemic hypertension if significant absorption occurs.

Phenylephrine Hydrochloride should be used with caution in specific clinical situations.

Avoid use in narrow‑angle glaucoma: risk of precipitating acute angle‑closure attack. Use with care in patients with hypertension: monitor blood pressure if systemic absorption is possible. Do not exceed recommended frequency: excessive dosing may increase intra‑ocular pressure. Check for hypersensitivity to phenylephrine or formulation excipients before use. Store at room temperature: keep in the original container, protect from light and moisture.

Phenylephrine Hydrochloride can interact with systemic and ocular agents that affect adrenergic pathways.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause hypertensive crisis with systemic absorption. - Other potent ocular vasoconstrictors: risk of excessive vasoconstriction and ischemia.

Moderate Interactions (Monitor Closely):\n- Antihypertensive medications: may blunt systemic blood‑pressure effects. - Beta‑blocker eye drops: potential additive effect on intra‑ocular pressure. - Other mydriatic agents: may lead to prolonged dilation and discomfort.